High Tide Acquires 51% Stake in Remexian Pharma GmbH

September 2, 2025

High Tide Inc. has completed the acquisition of a 51% interest in German medical cannabis importer and wholesaler Remexian Pharma GmbH for an estimated purchase price of €26.4 million, implying an enterprise value of €53.4 million. The deal was satisfied with cash, a seller loan and High Tide shares; High Tide holds a five-year option to acquire the remaining 49% (with call/put mechanics and pricing formulas tied to EBITDA).

Buyers
High Tide Inc.
Targets
Remexian Pharma GmbH
Sellers
Remexian's owners
Industry
Pharmaceuticals
Location
Brandenburg, Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.